Search | IOVS | ARVO Journals

View

Showing 1 – 9 of 9

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Clinical and functional effect of intravitreal injection of anti-IL-6 antibody on experimental autoimmune uveitis (EAU) in mice

Kristin Hösel; Büsra Chasan; Christoph Ehlken; Jan Tode; Stefan Rose-John; Johann Roider

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2220 – A0516. doi:

ARVO Annual Meeting Abstract June 2021

Self-Examination Low-Cost Full-Field OCT (SELFF-OCT) for Age-Related Macular Degeneration

Claus von der Burchard; Helge Sudkamp; Jan Tode; Christoph Ehlken; Konstantine Purtskhvanidze; Moritz Moltmann; Britta Heimes-Bussmann; Peter Koch; Michael Münst; Malte vom Endt; Timo Kepp; Dirk Theisen-Kunde; Inke König; Gereon Huttmann; Johann Roider

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1927. doi:

ARVO Annual Meeting Abstract July 2019

Off-Axis Full-Field Time-Domain OCT allows retinal self-scan in the patients with retinal diseases

Claus von der Burchard; Jan Tode; Moritz Moltmann; Christoph Ehlken; Peter Koch; Helge Sudkamp; Malte vom Endt; Dirk Theisen-Kunde; Reginald Birngruber; Gereon Huttmann; Johann Roider

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1353. doi:

ARVO Annual Meeting Abstract July 2018

Low-Cost Home-Care OCT for AMD with Off-Axis Full-Field Time-Domain OCT – Analysis of Reliability and Feasibility in Disease Monitoring

Claus von der Burchard; Jan Tode; Stefan Otto Johannes Koinzer; Christoph Ehlken; Felix Treumer; Peter Koch; Helge Sudkamp; Reginald Birngruber; Gereon Hüttmann; Johann Roider

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4484. doi:

ARVO Annual Meeting Abstract June 2017

2mm Central Macular Volume Scan Is Sufficient to Detect Exudative Age-related Macular Degeneration Activity in Optical Coherence Tomography

Claus Christian von der Burchard; Jan Tode; Christoph Ehlken; Johann Roider

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):374. doi:

ARVO Annual Meeting Abstract September 2016

Anti-VEGF injection patterns and five year functional outcomes in patients with choroidal neovascularization or macular edema

Thomas Wecker; Christoph Ehlken; Anima Buehler; Clemens Lange; Hansjürgen Agostini; Daniel Boehringer; Andreas Stahl

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):546. doi:

ARVO Annual Meeting Abstract September 2016

Clinical Experience with Eplerenone to Treat Chronic Central Serous Chorioretinopathy

Bertan Deniz Cakir; Franziska Fischer; Andreas Stahl; Christoph Ehlken; Anima Buehler; Gunther R Schlunck; Daniel Boehringer; Hansjürgen Agostini; Clemens Lange

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5342. doi:

ARVO Annual Meeting Abstract April 2014

Optical coherence tomography in the diagnosis and management of age-related macular degeneration

Christine Maria Schmucker; Gianni Virgili; Gerta Ruecker; Hansjuergen Agostini; Christoph Ehlken

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3369. doi:

ARVO Annual Meeting Abstract March 2012

A Safety Review Of Bevacizumab And Ranibizumab: Off-label Versus Goldstandard

Christine Schmucker; Yoon K. Loke; Hansjuergen T. Agostini; Lutz L. Hansen; Monika Lelgemann; Gerd Antes; Christoph Ehlken

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3806. doi:

Advertisement